Is it time for individualized thromboprophylaxis regimens in the ICU?

Critical Care Medicine

Volumn 43, Issue 2, 2015, Pages 500-501

  Welsby, Ian ^a   Ortel, Thomas L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTENSIVE FACTOR; PROTAMINE; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; CRITICALLY ILL PATIENT; DRUG SAFETY; DRUG TREATMENT FAILURE; EDITORIAL; HEALTH CARE QUALITY; HUMAN; HYPERCOAGULABILITY; INTENSIVE CARE UNIT; MULTICENTER STUDY (TOPIC); PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOCYTOPENIA; THROMBOSIS PREVENTION; VENOUS STASIS; VENOUS THROMBOEMBOLISM; CRITICAL ILLNESS; FEMALE; MALE; STATISTICS AND NUMERICAL DATA;

ANTICOAGULANTS; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; VENOUS THROMBOEMBOLISM;

EID: 84925321819     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000784     Document Type: Editorial

References (11)

1. Cook D, Meade M, Guyatt G, et al: Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 2011; 364:1305-1314
2. Gould MK, Garcia DA, Wren SM, et al; American College of Chest Physicians: Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e227S-e277S
3. Kahn SR, Lim W, Dunn AS, et al; American College of Chest Physicians: Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e195S-e226S
4. Lim W, Meade M, Lauzier F, et al; for the PROphylaxis for ThromboEmbolism in Critical care Trial Investigators, the Canadian Critical Care Trials Group, and the Australian and New Zealand Intensive Care Society Clinical Trials Group: Failure of Anticoagulant Thromboprophylaxis: Risk Factors in Medical-Surgical Critically Ill Patients. Crit Care Med 2015; 43:401-410
5. Kakkos SK, Caprini JA, Geroulakos G, et al: Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev 2008; 4:CD005258
6. Robinson S, Zincuk A, Larsen UL, et al: A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: A double-blinded, randomised controlled trial. Crit Care 2013; 17:R75
7. al Dieri R, Alban S, Béguin S, et al: Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time. J Thromb Haemost 2004; 2:1395-1401
8. Bloemen S, Hemker HC, Al Dieri R: Large inter-individual variation of the pharmacodynamic effect of anticoagulant drugs on thrombin generation. Haematologica 2013; 98:549-554
9. Ay C, Dunkler D, Simanek R, et al: Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: Results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 2011; 29:2099-2103
10. Al Dieri R, Peyvandi F, Santagostino E, et al: The thrombogram in rare inherited coagulation disorders: Its relation to clinical bleeding. Thromb Haemost 2002; 88:576-582
11. Kashuk JL, Moore EE, Sabel A, et al: Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery 2009; 146:764-772; discussion 772-764